MedTrace Logo

Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

NCT04812951 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2023-02-14

No results posted yet for this study

Summary

Use of Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in cataract Surgery

Conditions

  • Ocular Surface Disease
  • Ocular Inflammation

Interventions

DRUG

CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion

one cyclosporine 0.1% eye drop twice a day for 30 preoperative days

DEVICE

cationorm eye drops

one cationorm eye drop twice a day for 30 preoperative days

Sponsors & Collaborators

  • Campus Bio-Medico University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2021-06-18
Completion
2022-02-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812951 on ClinicalTrials.gov